MBMartin de Boer

Martin de Boer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martin de Boer has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MKL1 deficiency results in a severe neutrophil motility defect due to impaired actin polymerization

    by Evelien G. G. Sprenkeler, Stefanie S. V. Henriet, Anton T. J. Tool, Iris C. Kreft, Ivo van der Bijl, Cathelijn C.E.M. Aarts, Michel van Houdt, Paul J. J. H. Verkuijlen, Koen van Aerde, Gerald Jaspers, et al.

    Megakaryoblastic leukemia 1 (MKL1) promotes the regulation of essential cell processes, including actin cytoskeletal dynamics by co-activating serum response factor. Recently, the first human case with MKL1 deficiency, leading to a novel primary immunodeficiency, was identified. We report a second family with two siblings with a homozygous frameshift mutation in MKL1. The index case deceased as an infant from progressive and severe pneumonia by Pseudomonas aeruginosa and poor wound healing. The younger sib was preemptively transplanted shortly after birth. The immunodeficiency was marked by a pronounced actin polymerization defect and a strongly reduced motility and chemotactic response by MKL1-deficient neutrophils. Apart from the lack of MKL1, subsequent proteomic and transcriptomic analyses of patient neutrophils revealed actin and several actin-related proteins to be downregulated, confirming a role for MKL1 as transcriptional co-regulator. Degranulation was enhanced upon suboptimal neutrophil activation, while production of reactive oxygen species was normal. Neutrophil adhesion was intact but without proper spreading. The latter could explain the observed failure in firm adherence and transendothelial migration under flow conditions. No apparent defect in phagocytosis and bacterial killing was found. Also monocyte-derived macrophages showed intact phagocytosis; lymphocyte counts and proliferative capacity were normal. Non-hematopoietic primary patient fibroblasts demonstrated defective differentiation into myofibroblasts but normal migration and filamentous actin (F-actin) content, most probably due to compensatory mechanisms of MKL2, which is not expressed in neutrophils. Our findings extend current insight into the severe immune dysfunction in MKL1 deficiency, with cytoskeletal dysfunction and defective extravasation of neutrophils as most prominent features.


  • p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease

    by Gouri P. Hule, Purva R. Kanvinde, Manasi A. Kulkarni, Karin van Leeuwen, Martin de Boer, Umair Ahmed Bargir, Prasad D. Taur, Mukesh M. Desai, Manisha R. Madkaikar


  • Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children

    by Shahram Nemati, Shahram Teimourian, Mina Tabrizi, Mehri Najafi, Naghi Dara, Farid Imanzadeh, Mitra Ahmadi, Maryam Kazemi Aghdam, Mohmoud Tavassoli, Pejman Rohani, et al.


  • Two X-Linked Chronic Granulomatous Disease Patients with Unusual NADPH Oxidase Properties

    by Baruch Wolach, Arnon Broides, Tal Zeeli, Ronit Gavrieli, Martin de Boer, Karin van Leeuwen, Jacov Levy, Dirk Roos

    Chronic granulomatous disease (CGD) is an immune deficiency syndrome caused by defects in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the enzyme that generates reactive oxygen species (ROS) in phagocytizing leukocytes. This study evaluates the NADPH oxidase capacity in two X-linked CGD patients with mutations in gp91phox that alter the regions in this membrane-bound NADPH oxidase component involved in docking of the cytosolic component p47phox. Hydrogen peroxide and superoxide generation, bactericidal activity, and NADPH oxidase protein expression by the patients’ neutrophils were measured, and genetic analysis was performed. We report two patients, each with a novel missense mutation in CYBB, the gene that encodes gp91phox. Surprisingly, neutrophils from these patients showed total absence of superoxide production, although they retained 13–30% of the hydrogen peroxide production capability. We speculate that this is due to direct electron transfer from flavin adenine dinucleotide (FAD) in gp91phox to oxygen, leading to inefficient hydrogen peroxide formation instead of efficient superoxide production. X-linked CGD patients with mutations that alter the gp91phox protein in regions involved in docking of the cytosolic NADPH oxidase component p47phox may have higher than expected hydrogen peroxide generation capability.